Publication | Closed Access

A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood–Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats

InflammationCannabis UseMicroglial ActivationBlood–brain BarrierMedicineMatrix Metalloproteinase ExpressionNeuropharmacologyBrain-immune InteractionNeuroprotectionNeuroscienceCerebral Blood FlowPharmacologyCannabinoid PharmacologyNeuroimmunologyCannabinoid Receptor 2Neuroinflammation